Optimal Management of PPI-Refractory GERD with Hiatal Hernia

First-Line Strategy: Optimizing Current PPI Therapy

The American Gastroenterological Association recommends optimizing current PPI therapy by switching to twice-daily dosing of the current PPI, such as pantoprazole 40 mg twice daily, taken 30-60 minutes before breakfast and dinner, before considering treatment failure, and adding an H2-receptor antagonist at bedtime for breakthrough nighttime symptoms 1, 2, 3
Expert consensus recommends twice-daily PPI therapy for patients not responding to once-daily dosing, despite limited trial data supporting this approach, with the goal of maximizing acid suppression 1, 2, 4
The American Gastroenterological Association suggests considering switching PPIs if side effects, such as headache, diarrhea, constipation, or abdominal pain, are problematic, as an alternative PPI may help alleviate these issues 1, 4

The American Gastroenterological Association recommends adding an H2-receptor antagonist, such as famotidine or ranitidine, for breakthrough symptoms, particularly at bedtime, as these agents work through a different mechanism than PPIs and can provide additional acid suppression 1, 3
H2RAs are more effective than placebo but less effective than PPIs as monotherapy, and may be used as adjunctive therapy to PPIs for nighttime symptoms 1, 3

The American Gastroenterological Association recommends using antacids or alginate-containing antacids for on-demand breakthrough symptoms, as these agents provide rapid relief from symptoms 1, 3, 4
Alginate-containing antacids may be particularly helpful for extraesophageal reflux symptoms, and can be combined with H2RAs or PPIs to sustain efficacy 1, 3, 4

The American Gastroenterological Association recommends lifestyle modifications, such as elevating the head of the bed 6-8 inches, avoiding meals within 2-3 hours of bedtime, weight loss if overweight or obese, avoiding specific trigger foods, and smoking cessation, as these can significantly impact treatment success 1, 3
These modifications can help reduce nocturnal acid exposure, prevent or postpone the need for escalating acid suppression, and improve overall symptoms 1, 3

The American Gastroenterological Association recommends diagnostic evaluation, including endoscopy with biopsy, esophageal manometry, and ambulatory pH monitoring, for patients who do not respond to twice-daily PPI therapy, to evaluate for complications, alternative diagnoses, or metaplasia/dysplasia 2, 4
These tests can help identify underlying causes of symptoms and guide further treatment 2, 4

The American College of Chest Physicians recommends considering antireflux surgery for patients who fail intensive medical therapy and have objective evidence of GERD on testing, as surgery may provide significant improvement in symptoms 5
Studies show 86-100% improvement in chronic cough and GERD symptoms 12 months following surgery in patients who failed intensive medical therapy, and surgery may be particularly appropriate when symptoms persist despite total or near-total elimination of esophageal acid on 24-hour pH monitoring 5